`Going overboard`: FDA withdraws Cipla licence cancellation order after Bombay HC raps it
· Business · Zee News, Moneycontrol, Times of India
The Bombay High Court reprimanded the drug regulator for issuing an overbroad licence cancellation order against pharmaceutical major Cipla. Following the court's intervention, the Drug Controller General of India formally withdrew the cancellation order. The legal challenge arose after the regulatory body suspended Cipla's manufacturing licence without adequately specifying the grounds or individual product infractions. The high court's scrutiny addressed procedural lapses in how regulatory suspensions are administered across the pharmaceutical sector. Cipla continues its manufacturing and distribution operations following the withdrawal of the punitive order.
Why it matters
The ruling protects Cipla from operational disruption and sets a legal precedent requiring regulatory authorities to follow transparent, specific procedures before suspending pharmaceutical licences.
Read the original report — Zee News
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.